胃肠道功能障碍在帕金森病的临床生物学概况上有所作为
Jacopo Bissacco1, Roberta Bovenzi1, Matteo Conti1
1Unit of Neurology, Department of Systems Medicine, Tor Vergata University of Rome, Roma, Italy.
Movement disorders clinical practice
|December 20, 2024
概括
帕金森病 (PD) 的胃肠道功能障碍随着疾病的进展而恶化. 特定的免疫和神经退行标志物与早期与晚期PD的肠道问题有不同的相关性.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 胃肠道功能障碍 (GID) 是帕金森病 (PD) 所有阶段的常见但复杂的特征.
- 在PD患者中,GID会影响不同的临床和病理路径.
- 了解GID和生物标志物之间的相互作用对于PD管理至关重要.
研究的目的:
- 在帕金森病中探索GID和外周免疫标记物之间的关系.
- 研究帕金森病中GID和神经退行症标志物之间的关联.
主要方法:
- 114名帕金森病患者 (55名新生患者,59名中级患者) 完成了胃肠道功能障碍PD (GIDS-PD) 尺度.
- 评估了动力和非动力秤.
- 脑脊液 (CSF) 的粉胺-β42,粉胺-β42/β40,总-tau,酸化-181-tau和总α-synuclein的水平被测量,同时测量了专蛋白比率和周围血液细胞计数.
主要成果:
- 中晚期PD患者的GID比新生患者更高.
- GIDS-PD分数与运动和非运动分数相关,特别是在新生患者中.
- 在新的PD中,GID与α-synuclein相关,反向与淋巴细胞相关. 在这两组中,GID与蛋白和白蛋白比率呈正相关,与粉样β酸呈负相关.
结论:
- 随着帕金森病的进展,GID的严重程度会升级.
- 截然不同的临床和生物模式与PD不同阶段的GID有关.
- 这些发现突出了GID和PD中的生物标志物之间的特定阶段关系.
相关概念视频
01:15Parkinson's Disease: Overview
476
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
476
01:24Parkinson's Disease: Treatment
216
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
216
01:37Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
01:20Gastrointestinal Motility Disorders
256
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
256
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
253
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
253
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K